

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000161"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000161" />

    <meta name="citation_title" content="On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis"/>
    <meta itemprop="name" content="On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis"/>

      <meta name="citation_author" content="Robert J. Greenstein"/>
            <meta name="citation_author_institution" content="Laboratory of Molecular Surgical Research, VA Medical Center, Bronx, New York, United States of America"/>
      <meta name="citation_author" content="Liya Su"/>
            <meta name="citation_author_institution" content="Laboratory of Molecular Surgical Research, VA Medical Center, Bronx, New York, United States of America"/>
      <meta name="citation_author" content="Vahram Haroutunian"/>
            <meta name="citation_author_institution" content="Psychiatry, VA Medical Center, Bronx, New York, United States of America"/>
      <meta name="citation_author" content="Azra Shahidi"/>
            <meta name="citation_author_institution" content="Microbiology, VA Medical Center, Bronx, New York, United States of America"/>
      <meta name="citation_author" content="Sheldon T. Brown"/>
            <meta name="citation_author_institution" content="Infectious Diseases, VA Medical Center, Bronx, New York, United States of America"/>

    <meta name="citation_date" content="2007/1/24"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000161.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e161"/>
    <meta name="citation_issue" content="1"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Ein eigenthumlicher fall von tuberculose beim rind (A particular case of tuberculosis in a cow).; citation_author=HA Johne; citation_author=L Frothingham; citation_journal_title=Dtsch Zeitschr Tiermed, Vergl Pathol; citation_volume=21; citation_number=1; citation_pages=438-454; citation_date=1895; " />
      <meta name="citation_reference" content="citation_title=Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?; citation_author=RJ Greenstein; citation_author=MT Collins; citation_journal_title=Lancet; citation_volume=364; citation_number=2; citation_pages=396-397; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease.; citation_author=SA Naser; citation_author=G Ghobrial; citation_author=C Romero; citation_author=JF Valentine; citation_journal_title=Lancet; citation_volume=364; citation_number=3; citation_pages=1039-1044; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=The Mycobacterium avium subspecies paratuberculosis problem and its relation to the causation of Crohn disease.; citation_author=J Hermon-Taylor; citation_author=FAK El-Zaatari; citation_number=4; citation_pages=74-94; citation_date=2004; citation_publisher=IWA Publishing.; " />
      <meta name="citation_reference" content="citation_title=Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease.; citation_author=RJ Greenstein; citation_journal_title=Lancet Infect Dis; citation_volume=3; citation_number=5; citation_pages=507-514; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=On the etiology of Crohn disease.; citation_author=D Mishina; citation_author=P Katsel; citation_author=ST Brown; citation_author=EC Gilberts; citation_author=RJ Greenstein; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=93; citation_number=6; citation_pages=9816-9820; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease.; citation_author=F Autschbach; citation_author=S Eisold; citation_author=U Hinz; citation_author=S Zinser; citation_author=M Linnebacher; citation_journal_title=Gut; citation_volume=54; citation_number=7; citation_pages=944-949; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Phenotype at diagnosis predicts recurrence rates in Crohn's disease.; citation_author=FL Wolters; citation_author=MG Russel; citation_author=J Sijbrandij; citation_author=T Ambergen; citation_author=S Odes; citation_journal_title=Gut; citation_number=8; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Inflammatory mediators in chronic inflammatory bowel diseases.; citation_author=V Gross; citation_author=T Andus; citation_author=HG Leser; citation_author=M Roth; citation_author=J SchÃ¶lmerich; citation_journal_title=KlinWochenschr; citation_volume=69; citation_number=9; citation_pages=981-987; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism.; citation_author=DC Baumgart; citation_author=K Vierziger; citation_author=A Sturm; citation_author=B Wiedenmann; citation_author=AU Dignass; citation_journal_title=Scand J Gastroenterol; citation_volume=40; citation_number=10; citation_pages=958-964; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase.; citation_author=C Peifer; citation_author=G Wagner; citation_author=S Laufer; citation_journal_title=Curr Top Med Chem; citation_volume=6; citation_number=11; citation_pages=113-149; citation_date=2006; " />
      <meta name="citation_reference" content="citation_author=LJ Kleinsmith; citation_number=12; citation_date=2006; citation_publisher=Pearson Benjamin Cummings; " />
      <meta name="citation_reference" content="citation_title=Treatment of patients with aggressive lymphomas: an overview.; citation_author=WJ Urba; citation_author=PL Duffey; citation_author=DL Longo; citation_journal_title=J Natl Cancer Inst Monogr; citation_number=13; citation_pages=29-37; citation_date=1990; " />
      <meta name="citation_reference" content="citation_title=Chemotherapy of Neoplastic Diseases.; citation_author=P Calabresi; citation_author=BA Chabner; citation_number=14; citation_pages=1202-1208; citation_date=1990; citation_publisher=Pergamon Press.; " />
      <meta name="citation_reference" content="citation_title=Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.; citation_author=BG Feagan; citation_author=J Rochon; citation_author=RN Fedorak; citation_author=EJ Irvine; citation_author=G Wild; citation_journal_title=N Engl J Med; citation_volume=332; citation_number=15; citation_pages=292-297; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity.; citation_author=CN Bernstein; citation_author=L Artinian; citation_author=PA Anton; citation_author=F Shanahan; citation_journal_title=Dig Dis Sci; citation_volume=39; citation_number=16; citation_pages=1638-1641; citation_date=1994; " />
      <meta name="citation_reference" content="citation_title=Metabolism of 6-Mercaptopurine by Resistant Escherichia coli Cells.; citation_author=JH Coggin; citation_author=M Loosemore; citation_author=WR Martin; citation_journal_title=J Bacteriol; citation_volume=92; citation_number=17; citation_pages=446-454; citation_date=1966; " />
      <meta name="citation_reference" content="citation_title=Utilization And Interconversion Of Purine Bases And Ribonucleosides By Salmonella Typhimurium.; citation_author=EF Zimmerman; citation_author=B Magasanik; citation_journal_title=J Biol Chem; citation_volume=239; citation_number=18; citation_pages=293-300; citation_date=1964; " />
      <meta name="citation_reference" content="citation_title=Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) (2006); citation_number=19; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease.; citation_author=RJ Chiodini; citation_author=HJ Van Kruiningin; citation_author=WJ Thayer; citation_author=J Coutu; citation_journal_title=JClinMicrobiol; citation_volume=24; citation_number=20; citation_pages=357-363; citation_date=1986; " />
      <meta name="citation_reference" content="citation_title=Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex.; citation_author=MA Bertram; citation_author=CB Inderlied; citation_author=S Yadegar; citation_author=P Kolanoski; citation_author=JK Yamada; citation_journal_title=J Infect Dis; citation_volume=154; citation_number=21; citation_pages=194-195; citation_date=1986; " />
      <meta name="citation_reference" content="citation_title=Growth of Mycobacterium paratuberculosis in radiometric, Middlebrook and egg-based media.; citation_author=JJ Damato; citation_author=MT Collins; citation_journal_title=Vet Microbiol; citation_volume=22; citation_number=22; citation_pages=31-42; citation_date=1990; " />
      <meta name="citation_reference" content="citation_title=Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol.; citation_author=N Rastogi; citation_author=KS Goh; citation_author=V Labrousse; citation_journal_title=AntimicrobAgents Chemother; citation_volume=36; citation_number=23; citation_pages=2843-2846; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=IS900, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium.; citation_author=ZM Kunze; citation_author=S Wall; citation_author=R Appelberg; citation_author=MT Silva; citation_author=F Portaels; citation_journal_title=Molecular Microbiology; citation_volume=5; citation_number=24; citation_pages=2265-2272; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=Biologically distinct subtypes of Mycobacterium avium differ in possession of insertion sequence IS901.; citation_author=ZM Kunze; citation_author=F Portaels; citation_author=JJ McFadden; citation_journal_title=J Clin Microbiol; citation_volume=30; citation_number=25; citation_pages=2366-2372; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Methotrexate in Non Hodgkin's Lymphoma.; citation_author=RS Findley; citation_author=CL Fortner; citation_number=26; citation_pages=1509-1513; citation_date=1996; citation_publisher=Williams & Wilkins.; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000161" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis"/>
    <meta name="twitter:description" content="BackgroundClinical improvement in inflammatory bowel disease (IBD) treated with methotrexate and 6-mercaptopurine (6-MP) is associated with a decrease in pro-inflammatory cytokines. This has been presumed to indicate the mechanism of action of methotrexate and 6-MP. Although controversial, there are increasingly compelling data that Mycobacterium avium subspecies paratuberculosis (MAP) may be an etiological agent in some or all of IBD. We hypothesized that the clinical efficacy of methotrexate and 6-MP in IBD may be to simply inhibit the growth of MAP.MethodologyThe effect on MAP growth kinetics by methotrexate and 6-MP were evaluated in cell culture of two strains each of MAP and M. avium using a radiometric (14CO2 BACTEC&reg;) detection system that quantifies mycobacterial growth as arbitrary &ldquo;growth index units&rdquo; (GI). Efficacy data are presented as &ldquo;percent decrease in cumulative GI&rdquo; (% &minus;&Delta;cGI).Principal FindingsThe positive control antibiotic (clarithromycin) has &ge;85% &minus;&Delta;cGI at a concentration of 0.5 &micro;g/ml. The negative control (ampicillin) has minimal inhibition at 64 &micro;g/ml. MAP ATCC 19698 shows &ge;80% &minus;&Delta;cGI for both agents by 4 &micro;g/ml. With the other three isolates, although more effective than ampicillin, 6-MP is consistently less effective than methotrexate.ConclusionsWe show that methotrexate and 6-MP inhibit MAP growth in vitro. Each of the four isolates manifests different % &minus;&Delta;cGI. These data are compatible with the hypothesis that the clinical improvement in patients with IBD treated with methotrexate and 6-MP could be due to treating a MAP infection. The decrease in pro-inflammatory cytokines, thought to be the primary mechanism of action, may simply be a normal, secondary, physiological response. We conclude that henceforth, in clinical studies that evaluate the effect of anti-MAP agents in IBD, the use of methotrexate and 6-MP should be excluded from any control groups."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000161.g002"/>

  <meta property="og:title" content="On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000161" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=8406'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=5248'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=1533&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000161">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000161" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000161&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    On the Action of Methotrexate and 6-Mercaptopurine on <i>M. avium</i> Subspecies <i>paratuberculosis</i>
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Robert J. Greenstein
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:BGAxis@aol.com">BGAxis@aol.com</a>
            </p>

                <p>Affiliation:
                  Laboratory of Molecular Surgical Research, VA Medical Center, Bronx, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Liya Su, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Laboratory of Molecular Surgical Research, VA Medical Center, Bronx, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Vahram Haroutunian, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Psychiatry, VA Medical Center, Bronx, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Azra Shahidi, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Microbiology, VA Medical Center, Bronx, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Sheldon T. Brown
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Infectious Diseases, VA Medical Center, Bronx, New York, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: January 24, 2007</li>
    <li>DOI: 10.1371/journal.pone.0000161</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000161" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000161" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000161" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000161" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000161-t001" data-doi="info:doi/10.1371/journal.pone.0000161" data-uri="info:doi/10.1371/journal.pone.0000161.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000161.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000161-g001" data-doi="info:doi/10.1371/journal.pone.0000161" data-uri="info:doi/10.1371/journal.pone.0000161.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000161.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000161-g002" data-doi="info:doi/10.1371/journal.pone.0000161" data-uri="info:doi/10.1371/journal.pone.0000161.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000161.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000161">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000161" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Clinical improvement in inflammatory bowel disease (IBD) treated with methotrexate and 6-mercaptopurine (6-MP) is associated with a decrease in pro-inflammatory cytokines. This has been presumed to indicate the mechanism of action of methotrexate and 6-MP. Although controversial, there are increasingly compelling data that <em>Mycobacterium avium</em> subspecies <em>paratuberculosis</em> (MAP) may be an etiological agent in some or all of IBD. We hypothesized that the clinical efficacy of methotrexate and 6-MP in IBD may be to simply inhibit the growth of MAP.</p>


<h3>Methodology</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>The effect on MAP growth kinetics by methotrexate and 6-MP were evaluated in cell culture of two strains each of MAP and <em>M. avium</em> using a radiometric (<sup>14</sup>CO<sub>2</sub> BACTECÂ®) detection system that quantifies mycobacterial growth as arbitrary âgrowth index unitsâ (GI). Efficacy data are presented as âpercent decrease in cumulative GIâ (% âÎcGI).</p>


<h3>Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>The positive control antibiotic (clarithromycin) has â¥85% âÎcGI at a concentration of 0.5 Âµg/ml. The negative control (ampicillin) has minimal inhibition at 64 Âµg/ml. MAP ATCC 19698 shows â¥80% âÎcGI for both agents by 4 Âµg/ml. With the other three isolates, although more effective than ampicillin, 6-MP is consistently less effective than methotrexate.</p>


<h3>Conclusions</h3>
<a id="article1.front1.article-meta1.abstract1.sec4.p1" name="article1.front1.article-meta1.abstract1.sec4.p1"></a><p>We show that methotrexate and 6-MP inhibit MAP growth <em>in vitro</em>. Each of the four isolates manifests different % âÎcGI. These data are compatible with the hypothesis that the clinical improvement in patients with IBD treated with methotrexate and 6-MP could be due to treating a MAP infection. The decrease in pro-inflammatory cytokines, thought to be the primary mechanism of action, may simply be a normal, secondary, physiological response. We conclude that henceforth, in clinical studies that evaluate the effect of anti-MAP agents in IBD, the use of methotrexate and 6-MP should be excluded from any control groups.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Greenstein RJ, Su L, Haroutunian V, Shahidi A, Brown ST (2007) On the Action of Methotrexate and 6-Mercaptopurine on <em>M. avium</em> Subspecies <em>paratuberculosis</em>
            . PLoS ONE 2(1):
          e161.
            doi:10.1371/journal.pone.0000161</p><p><strong>Academic Editor: </strong>Debbie Fox, The Research Institute for Children, United States of America</p><p><strong>Received:</strong> November 10, 2006; <strong>Accepted:</strong> December 12, 2006; <strong>Published:</strong> January 24, 2007</p><p>This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.</p><p><strong>Funding: </strong>There was no extramural funding for this study. All were provided from in-house or personal funds.</p><p><strong>Competing interests:</strong> The corresponding author (RJG) has submitted provisional patent applications based on the hypotheses that were tested in this study. The final author (STB) was a member of the National Academy of Sciences panel that issued the 2003 report entitled âDiagnosis and Control of Johne's Diseaseâ.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>
            <em>Mycobacterium avium</em> subspecies <em>paratuberculosis</em> (MAP) causes Johne's disease <a href="#pone.0000161-Johne1">[1]</a> in cattle worldwide. Johne's disease is clinically evocative of inflammatory bowel disease (IBD) in humans. The possibility that MAP may be zoonotic <a href="#pone.0000161-Greenstein1">[2]</a> is the subject of much interest <a href="#pone.0000161-Naser1">[3]</a> 
            <a href="#pone.0000161-HermonTaylor1">[4]</a> (&amp; see <a href="#pone.0000161-Greenstein2">[5]</a> for review.) Since first seeing our MAP RNA data <a href="#pone.0000161-Mishina1">[6]</a>, we have posited in private, in peer reviewing manuscripts <a href="#pone.0000161-Naser1">[3]</a>, <a href="#pone.0000161-Autschbach1">[7]</a>, <a href="#pone.0000161-Wolters1">[8]</a>, and at professional congresses that MAP is the primary and most culpable, potential etiological agent for some or all of IBD.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>In the therapy of IBD, (and several other inflammatory diseases) both methotrexate and 6-MP are used because of empirical efficacy, even though their precise mechanism of action is unknown. <a href="#pone.0000161-Gross1">[9]</a> 
            <a href="#pone.0000161-Baumgart1">[10]</a>, <a href="#pone.0000161-Peifer1">[11]</a> Their use is attended by clinical improvement that is associated with a decrease in pro-inflammatory cytokines. Consequently, prevailing medical dogma posits that the mode of action of methotrexate and 6-MP, is to decrease the production of pro-inflammatory cytokines, and as a consequence the âinflammatoryâ response that is the consequence of these cytokines is diminished. This results in a clinical improvement in diseases that are conventionally conceptualized as being primarily âinflammatory.â</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>Both methotrexate and 6-MP interfere with DNA replication. Methotrexate acts by inhibiting dihydrofolate reductase, folate generation and the consequent production of adenine.<a href="#pone.0000161-Kleinsmith1">[12]</a> The mechanism of action of 6-MP is to substitute for guanine in DNA replication.<a href="#pone.0000161-Kleinsmith1">[12]</a> Because prokaryotes must synthesize their own folic acid, they should be more susceptible to folate inhibition than eukaryotes. It is noteworthy that there are two distinct doses in human clinical use for both methotrexate and 6-MP. Each agent has a âhighâ dose, (used in to treat reticuloendothelial malignancies <a href="#pone.0000161-Urba1">[13]</a>, <a href="#pone.0000161-Calabresi1">[14]</a>) and a âlowâ dose (used to treat âinflammatoryâ diseases. <a href="#pone.0000161-Feagan1">[15]</a> 
            <a href="#pone.0000161-Bernstein1">[16]</a>)</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>We hypothesized that the clinically relevant mechanism of action of âlowâ dose methotrexate and 6-MP in the therapy of IBD, may, in whole or part, be due to the inhibition of MAP growth. If this hypothesis is correct, the decrease in the pro-inflammatory cytokines, heretofore considered the primary mechanism of action of these two agents, could simply represent a secondary phenomenon. The observed decrease in pro-inflammatory cytokines could be ascribed to the treatment of the instigating MAP infection. To evaluate this hypothesis we have studied the effect of methotrexate and 6-MP on MAP and other <em>M. avium</em> isolates in culture. The effect of methotrexate has been evaluated on <em>E. coli</em> 
            <a href="#pone.0000161-Coggin1">[17]</a>, 6-MP on <em>Salmonella typhimurium</em> 
            <a href="#pone.0000161-Zimmerman1">[18]</a> and both agents on <em>M. tb</em>. <a href="#pone.0000161-1">[19]</a> To our knowledge, however, this is the first time that these two agents have been evaluated for their effect on MAP.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Methods"></a><h3>Methods</h3><a id="article1.body1.sec2.p1" name="article1.body1.sec2.p1"></a><p>This study was approved by the Research &amp; Development Committee at the VAMC Bronx NY (0720-06-038) and was conducted under the Institutional Radioactive Materials Permit (#31-00636-07).</p>

<h4>Culture</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>In this study, we used four well-characterized strains of mycobacteria. Two were MAP, a bovine isolate, ATCC 19698 (ATCC Rockville MD) and âDominicâ a human isolate from an individual with Crohn's disease (originally isolated by R. Chiodini <a href="#pone.0000161-Chiodini1">[20]</a>.) The <em>M. Avium</em> subspecies <em>avium</em> strains (hereinafter called <em>M. avium</em>) were ATCC 25291 (veterinary source) and <em>M. avium</em> 101 <a href="#pone.0000161-Bertram1">[21]</a>. Primary cultures were performed in Middlebrook 7H9 medium supplemented 9:1 with ADC (Both Difco. Detroit MI). All media for MAP (liquid and agar plates) were supplemented with 1 Âµg/ml Mycobactin J (Allied Monitor. Fayette MO.)</p>
<a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>The detergent Tween 80 (recommended to prevent mycobacterial clumping) renders clinically resistant strains of MAP inappropriately susceptible to antimicrobials in cell culture. <a href="#pone.0000161-Damato1">[22]</a> Accordingly in our experiments, Tween 80 was not used. To minimize mycobacterial clumping, one ml of the log phase bacterial culture (~GI of 500) in 7H12 medium in the BACTEC vial was passaged â¥20 times through a 25 gauge needle <a href="#pone.0000161-Rastogi1">[23]</a> on a one ml syringe (Becton-Dickerson Franklin Lakes NJ), added to five ml 7H9 medium supplemented with Mycobactin J, vortexed and left standing at ambient temperature for 30 minutes. Subsequently, only the upper three of the six ml. were used for inoculations. The number of CFU's inoculated was determined by plating serial dilutions of the inoculum onto 7H10 plates (Difco) supplemented for MAP with Mycobactin J (1 Âµg/ml) and counted when colonies were easily visualized (two to six weeks). At the time of passage, additional aliquots were plated onto blood agar plates to ensure that inocula were not contaminated with non-mycobacterial organisms.</p>
<a id="article1.body1.sec2.sec1.p3" name="article1.body1.sec2.sec1.p3"></a><p>To confirm the identity of the species studied, DNA was obtained from the isolates (High Pure Template Prep. Kit Roche Diagnostics Indianapolis IN), PCR amplified using primers for IS 900 (MAP) <a href="#pone.0000161-Kunze1">[24]</a>and IS 901/2 <a href="#pone.0000161-Kunze2">[25]</a> (<em>M. avium</em> &amp; specific subspecies including <em>silveticum</em>) as described. <a href="#pone.0000161-Mishina1">[6]</a> Amplicon sizes were determined using 1% agarose gel electrophoresis. DNA sequence analysis was performed commercially, (Genewiz North Brunswick NJ) with sequence comparison performed using BLAST (NLM).</p>
<a id="article1.body1.sec2.sec1.p4" name="article1.body1.sec2.sec1.p4"></a><p>The positive antibiotic control clarithromycin (gift of Abbott Chicago IL) was dissolved in methanol. The negative control antibiotic was ampicillin (Sigma St Louis MO) which was dissolved in water. Methotrexate and 6-mercaptopurine (both Sigma) were dissolved in NaOH at a maximal final concentration of 50 mM (Sigma). Control inocula were performed using the maximum concentration of each diluent. Agents were tested in serial dilutions from a minimum of 0.05 Âµg/ml to a maximum of 64 Âµg/ml (see individual Figures). Aliquots of chemicals being evaluated were prediluted, stored at â80Â°C, thawed, used once and discarded.</p>
<a id="article1.body1.sec2.sec1.p5" name="article1.body1.sec2.sec1.p5"></a><p>Data are presented as cumulative growth index (cGI) unitsÂ±SD (when necessary, see individual figures). The effect (or lack thereof) of each agent is presented as the percent decrease in cGI units (% â<em>Î</em>cGI), compared to the control cGI of that isolate in the diluent (e.g. methanol or NaOH) that was used for the specific chemical being evaluated. cGI data for each experiment is presented until the day prior to any GI reading exceeding the assay limit of â999â (<a href="#pone-0000161-t001">Table 1</a>). Raw data was archived onto Excel, and the cumulative results transferred to Prism (Graphpad, San Diego CA) for final graphing.</p>
<div class="figure" id="pone-0000161-t001"><div class="img"><a name="pone-0000161-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000161.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000161" data-uri="info:doi/10.1371/journal.pone.0000161.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000161.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000161.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000161.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000161.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000161.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000161.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000161.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000161.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000161.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Differences in growth kinetics and consequent length of experiment for each isolate.</span></strong></p><span>doi:10.1371/journal.pone.0000161.t001</span></div>
</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>Bacterial quantification must be performed retrospectively. Accordingly, for experimental reproducibility, bacterial passage and harvesting were performed when the GI was ~500. Quantification show that the CFU's of the <em>M. avium</em> isolates are approximately 10 fold higher (~1Ã10<sup>7</sup> CFU's/ml), compared to MAP (~1Ã10<sup>6</sup> CFU's/ml) (<a href="#pone-0000161-t001">Table 1</a>). Because of the difference in growth kinetics, <em>M. avium</em> CFU #âs inoculated were â¥10 fold lower than MAP (<a href="#pone-0000161-t001">Table 1</a>).</p>
<a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>Both of our MAP isolates (ATCC 19698 &amp; Dominic) were Mycobactin J dependant (data not presented), were IS 900 positive and had â¥99% homology with the GenBank accession NC_002944 of MAP (data not presented). <em>M. avium</em> ATCC 25 291 was positive for IS 902 and <em>M. avium</em> 101 was negative for both (Data not presented).</p>
<a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3"></a><p>In our pivotal study (<a href="#pone-0000161-g001">Figure 1</a>) the positive control antibiotic, clarithromycin exhibits â¥86% â<em>Î</em>cGI at the lowest concentration evaluated (0.5 Âµg/ml). The negative control antibiotic (the Î²âlactam, ampicillin) has a minimal effect (21% â<em>Î</em>cGI) at the 32 Âµg/ml. In contrast, 6-MP has an initial â¥43% â<em>Î</em>cGI starting at 1 Âµg/ml increasing to â¥84% â<em>Î</em>cGI at 4 Âµg/ml. Methotrexate has 40% â<em>Î</em>cGI inhibition at 2 Âµg /ml and â¥75% â<em>Î</em>cGI at 4 Âµg/ml. (<a href="#pone-0000161-g001">Figure 1</a>.)</p>
<div class="figure" id="pone-0000161-g001"><div class="img"><a name="pone-0000161-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000161.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000161" data-uri="info:doi/10.1371/journal.pone.0000161.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000161.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000161.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000161.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000161.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000161.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000161.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000161.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000161.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000161.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1. </strong></p><a id="article1.body1.sec3.fig1.caption1.p1" name="article1.body1.sec3.fig1.caption1.p1"></a><p>Shown is a bar graph of the cumulative GI data evaluating MAP ATCC 19698. Each drug dilution was studied in duplicate. Error bars are SD. There are three control inoculations, labeled on the abscissa as â0, 00 &amp; 000. The left hand â0â had an equal number of CFU's as in each drug studied. â00â  =  10 &amp; â000â  =  100 fold dilutions. In each control the maximum concentration of diluent used for each agent (methanol for Clarithromycin, water for ampicillin and NaOH for methotrexate and 6-MP) was added. Clarithromycin is most effective and ampicillin is the least effective at decreasing MAP growth. Both methotrexate and 6-MP are as effective as clarithromycin in MAP %â<em>Î</em>cGI at a dose of 4 Âµg/ml.</p>
<span>doi:10.1371/journal.pone.0000161.g001</span></div><a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4"></a><p>We additionally evaluated the effect of methotrexate and 6-MP against two MAP and two <em>M. avium</em> isolates (<a href="#pone-0000161-g002">Figure 2</a>). In these studies, the MAP 19698 results replicate the data presented in <a href="#pone-0000161-g001">Figure 1</a> showing ~80% â<em>Î</em>cGI inhibition at 4 Âµg/ml for both 6-MP and clarithromycin. In contrast, MAP Dominic shows less susceptibility to 6-MP (41% â<em>Î</em>cGI at 4 Âµg/ml) compared to MAP 19698 (84%â<em>Î</em>GI at 4 Âµg/ml). Both <em>M. avium</em> isolates show less susceptibility to 6-MP than to methotrexate (<a href="#pone-0000161-g002">Figure 2</a>). The diluent control inoculum for the <em>M. avium</em> ATCC 25291 appears to exhibit completely inhibited growth (<a href="#pone-0000161-g002">Figure 2:</a> Bottom left graph, left hand column.) However, over the following two days this methanol control entered log phase growth, whereas the vials at every clarithromycin dose continued to show no evidence of growth (data not presented.)</p>
<div class="figure" id="pone-0000161-g002"><div class="img"><a name="pone-0000161-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000161.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000161" data-uri="info:doi/10.1371/journal.pone.0000161.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000161.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000161.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000161.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000161.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000161.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000161.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000161.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000161.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000161.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2. </strong></p><a id="article1.body1.sec3.fig2.caption1.p1" name="article1.body1.sec3.fig2.caption1.p1"></a><p>A composite graph of the four bacterial strains studied. â0â is diluent control with an equal CFU inoculum and â00â is a 1:10 dilution of the water control inoculum. Drug concentrations are indicated on the abscissa. For each isolate, drug dose was studied in singlicate. For all four bacteria, clarithromycin has achieved maximal inhibition by 1 Âµg/ml. For MAP ATCC 19698, replicating data presented in <a href="#pone-0000161-g001">Figure 1</a>, both methotrexate and 6-MP %â<em>Î</em>GI is the same as for clarithromycin by 4 Âµg/ml. Note that with the other MAP isolate (Dominic) and both <em>M. avium</em> isolates, methotrexate is more effective at a lower dose than is 6-MP. The lower cumulative GI (seen on the ordinate) for the <em>M. avium</em> isolates is ascribable to their more rapid growth and earlier reaching the off scale BACTEC GI values of â999.â</p>
<span>doi:10.1371/journal.pone.0000161.g002</span></div></div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>The efficacy of both methotrexate and 6-MP in the therapy of IBD is uncontested. Prevailing dogma accepts that the decrease in pro-inflammatory cytokines that attends their use is responsible for their beneficial effect. In this study we show that both methotrexate and 6-MP inhibit the growth kinetics of MAP. In the event that IBD is eventually accepted as being due to a MAP infection, our data are compatible with our hypothesis that methotrexate and 6-MP may be impairing MAP growth. If so, the decrease in pro-inflammatory cytokines could simply be an appropriate physiological response to their antibiotic-like activity.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>We additionally show that there is a variation in response of the four different isolates to our tested agents. Three of the four isolates are more sensitive to methotrexate than to 6-MP. These observations need to be further evaluated in multiple isolates from a variety of individuals and clinical settings where development of MAP resistance may be responsible for a clinical deterioration. We conclude that antibiotic susceptibility testing will probably be indicated for putative MAP infections, just as they are for other (myco) bacterial infections.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>As is conventional with antibiotic susceptibility studies, we compared agents on an equal weight basis. However, methotrexate (MW 450) is a much larger molecule than 6-MP (MW 170) with a molar ratio of ~3:1. Thus, in comparison to 6-MP on a molar basis, methotrexate is an even more potent inhibitor of growth than our data indicate. Additionally, a simple extrapolation of our data to a comparison with conventional âantibioticsâ therapy is difficult. The dosages of methotrexate and 6-MP in clinical use have not been titrated according to standard antibiotic conventions. Dosage has been individualized, influenced by such factors as hematological toxicity and patient tolerance.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>There is a remarkable discrepancy between the doses of methotrexate and 6-MP, used to treat different diseases, that merit discussion. Each agent has a âhighâ dose, (used in to treat reticuloendothelial malignancies <a href="#pone.0000161-Urba1">[13]</a>, <a href="#pone.0000161-Calabresi1">[14]</a>) and a âlowâ dose (used to treat âinflammatoryâ diseases. <a href="#pone.0000161-Feagan1">[15]</a> 
            <a href="#pone.0000161-Bernstein1">[16]</a>) For methotrexate the antineoplastic dose may be 1500â5000 mg M<sup>2</sup> by IV infusion over 2â24 hours (for a 70 kg man this could equate to 7500 mg in 24 hours.)<a href="#pone.0000161-Findley1">[26]</a> In contrast, for IBD a typical dose is 25 mg PO or IM weekly. We suggest that this 300-fold disparity may reflect the difference between treating a eukaryotic reticuloendothelial malignancy and a prokaryotic mycobacterial (specifically we hypothesize in the case of IBD a MAP) infection.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>Our data are compatible with the thesis, but do not conclusively prove, that MAP may be zoonotic. Corroboration of our data will be necessary and multiple additional studies, both basic and clinical need to be performed. However, we suggest that, as a consequence of our observations antecedent clinical studies that have evaluated anti-MAP agents need to be reevaluated and that henceforth such studies will need to exclude methotrexate and 6-MP from âcontrolâ or placebo subjects.</p>

<h4>Conclusions and recommendations</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>We show that both methotrexate, as well as 6-MP, interfere with the growth of MAP, an organism that may be the etiological factor for some, or all of IBD. Some of the implications of these observations are discussed.</p>

</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>Thanks to Drs. R. Yalow, J. Uehlinger, D. Williams and G. P. S. Linn for their comments.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: RG SB. Performed the experiments: RG LS. Analyzed the data: RG LS VH AS SB. Contributed reagents/materials/analysis tools: RG VH AS SB. Wrote the paper: RG SB.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000161-Johne1" id="pone.0000161-Johne1"></a>Johne HA, Frothingham L (1895) Ein eigenthumlicher fall von tuberculose beim rind (A particular case of tuberculosis in a cow). Dtsch Zeitschr Tiermed, Vergl Pathol  21: 438â454.  <ul class="find" data-citedArticleID="926450"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Ein+eigenthumlicher+fall+von+tuberculose+beim+rind+%28A+particular+case+of+tuberculosis+in+a+cow%29.&amp;auth=&amp;atitle=Ein+eigenthumlicher+fall+von+tuberculose+beim+rind+%28A+particular+case+of+tuberculosis+in+a+cow%29." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Ein+eigenthumlicher+fall+von+tuberculose+beim+rind+%28A+particular+case+of+tuberculosis+in+a+cow%29." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Ein+eigenthumlicher+fall+von+tuberculose+beim+rind+%28A+particular+case+of+tuberculosis+in+a+cow%29.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000161-Greenstein1" id="pone.0000161-Greenstein1"></a>Greenstein RJ, Collins MT (2004) Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic? Lancet  364: 396â397.  <ul class="find" data-citedArticleID="926442" data-doi="10.1016/s0140-6736(04)16781-0"><li><a href="http://dx.doi.org/10.1016/s0140-6736(04)16781-0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Emerging+pathogens%3A+is+Mycobacterium+avium+subspecies+paratuberculosis+zoonotic%3F" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Emerging+pathogens%3A+is+Mycobacterium+avium+subspecies+paratuberculosis+zoonotic%3F%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000161-Naser1" id="pone.0000161-Naser1"></a>Naser SA, Ghobrial G, Romero C, Valentine JF (2004) Culture of <em>Mycobacterium avium</em> subspecies <em>paratuberculosis</em> from the blood of patients with Crohn's disease. Lancet  364: 1039â1044.  <ul class="find" data-citedArticleID="926460" data-doi="10.1016/s0140-6736(04)17058-x"><li><a href="http://dx.doi.org/10.1016/s0140-6736(04)17058-x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Culture+of+Mycobacterium+avium+subspecies+paratuberculosis+from+the+blood+of+patients+with+Crohn%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Culture+of+Mycobacterium+avium+subspecies+paratuberculosis+from+the+blood+of+patients+with+Crohn%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000161-HermonTaylor1" id="pone.0000161-HermonTaylor1"></a>Hermon-Taylor J, El-Zaatari FAK (2004)  The Mycobacterium avium subspecies paratuberculosis problem and its relation to the causation of Crohn disease. In: Pedley S, Bartram J, Rees G, Dufour A, Cotruvo J, editors. Pathogenic Mycobacteria in Water: A Guide to Public Health Consequences, Monitoring and Management. London, UK: IWA Publishing.. pp. 74â94.  1 ed. <ul class="find-nolinks"></ul></li><li><span class="label">5.
              </span><a name="pone.0000161-Greenstein2" id="pone.0000161-Greenstein2"></a>Greenstein RJ (2003) Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis  3: 507â514.  <ul class="find" data-citedArticleID="926444" data-doi="10.1016/s1473-3099(03)00724-2"><li><a href="http://dx.doi.org/10.1016/s1473-3099(03)00724-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Is+Crohn%27s+disease+caused+by+a+mycobacterium%3F+Comparisons+with+leprosy%2C+tuberculosis%2C+and+Johne%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Is+Crohn%27s+disease+caused+by+a+mycobacterium%3F+Comparisons+with+leprosy%2C+tuberculosis%2C+and+Johne%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000161-Mishina1" id="pone.0000161-Mishina1"></a>Mishina D, Katsel P, Brown ST, Gilberts EC, Greenstein RJ (1996) On the etiology of Crohn disease. Proc Natl Acad Sci U S A  93: 9816â9820.  <ul class="find" data-citedArticleID="926458" data-doi="10.1073/pnas.93.18.9816"><li><a href="http://dx.doi.org/10.1073/pnas.93.18.9816" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=On+the+etiology+of+Crohn+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22On+the+etiology+of+Crohn+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000161-Autschbach1" id="pone.0000161-Autschbach1"></a>Autschbach F, Eisold S, Hinz U, Zinser S, Linnebacher M, et al.  (2005) High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut  54: 944â949.  <ul class="find" data-citedArticleID="926422" data-doi="10.1136/gut.2004.045526"><li><a href="http://dx.doi.org/10.1136/gut.2004.045526" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=High+prevalence+of+Mycobacterium+avium+subspecies+paratuberculosis+IS900+DNA+in+gut+tissues+from+individuals+with+Crohn%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22High+prevalence+of+Mycobacterium+avium+subspecies+paratuberculosis+IS900+DNA+in+gut+tissues+from+individuals+with+Crohn%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000161-Wolters1" id="pone.0000161-Wolters1"></a>Wolters FL, Russel MG, Sijbrandij J, Ambergen T, Odes S, et al.  (2005) Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut.   <ul class="find" data-citedArticleID="926468" data-doi="10.1136/gut.2005.084061"><li><a href="http://dx.doi.org/10.1136/gut.2005.084061" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Phenotype+at+diagnosis+predicts+recurrence+rates+in+Crohn%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Phenotype+at+diagnosis+predicts+recurrence+rates+in+Crohn%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000161-Gross1" id="pone.0000161-Gross1"></a>Gross V, Andus T, Leser HG, Roth M, SchÃ¶lmerich J (1991) Inflammatory mediators in chronic inflammatory bowel diseases. KlinWochenschr  69: 981â987.  <ul class="find" data-citedArticleID="926446" data-doi="10.1007/bf01645143"><li><a href="http://dx.doi.org/10.1007/bf01645143" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Inflammatory+mediators+in+chronic+inflammatory+bowel+diseases." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Inflammatory+mediators+in+chronic+inflammatory+bowel+diseases.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000161-Baumgart1" id="pone.0000161-Baumgart1"></a>Baumgart DC, Vierziger K, Sturm A, Wiedenmann B, Dignass AU (2005) Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. Scand J Gastroenterol  40: 958â964.  <ul class="find" data-citedArticleID="926424" data-doi="10.1080/00365520510015854"><li><a href="http://dx.doi.org/10.1080/00365520510015854" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mesalamine+promotes+intestinal+epithelial+wound+healing+in+vitro+through+a+TGF-beta-independent+mechanism." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mesalamine+promotes+intestinal+epithelial+wound+healing+in+vitro+through+a+TGF-beta-independent+mechanism.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000161-Peifer1" id="pone.0000161-Peifer1"></a>Peifer C, Wagner G, Laufer S (2006) New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Curr Top Med Chem  6: 113â149.  <ul class="find" data-citedArticleID="926462" data-doi="10.2174/156802606775270323"><li><a href="http://dx.doi.org/10.2174/156802606775270323" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=New+approaches+to+the+treatment+of+inflammatory+disorders+small+molecule+inhibitors+of+p38+MAP+kinase." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22New+approaches+to+the+treatment+of+inflammatory+disorders+small+molecule+inhibitors+of+p38+MAP+kinase.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000161-Kleinsmith1" id="pone.0000161-Kleinsmith1"></a>Kleinsmith LJ (2006) Principles of Cancer Biology. San Francisco: Pearson Benjamin Cummings.   <ul class="find-nolinks"></ul></li><li><span class="label">13.
              </span><a name="pone.0000161-Urba1" id="pone.0000161-Urba1"></a>Urba WJ, Duffey PL, Longo DL (1990) Treatment of patients with aggressive lymphomas: an overview. J Natl Cancer Inst Monogr 29â37.  <ul class="find" data-citedArticleID="926466"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Treatment+of+patients+with+aggressive+lymphomas%3A+an+overview.&amp;auth=&amp;atitle=Treatment+of+patients+with+aggressive+lymphomas%3A+an+overview." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Treatment+of+patients+with+aggressive+lymphomas%3A+an+overview." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Treatment+of+patients+with+aggressive+lymphomas%3A+an+overview.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000161-Calabresi1" id="pone.0000161-Calabresi1"></a>Calabresi P, Chabner BA (1990)  Chemotherapy of Neoplastic Diseases. In: S. GL , Gilman A, Rall T, Nies AS, Taylor P, editors. The Pharmacological Basis of Therapeutics. New York: Pergamon Press.. pp. 1202â1208.  8 ed. <ul class="find-nolinks"></ul></li><li><span class="label">15.
              </span><a name="pone.0000161-Feagan1" id="pone.0000161-Feagan1"></a>Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, et al.  (1995) Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med  332: 292â297.  <ul class="find" data-citedArticleID="926438" data-doi="10.1056/nejm199502023320503"><li><a href="http://dx.doi.org/10.1056/nejm199502023320503" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Methotrexate+for+the+treatment+of+Crohn%27s+disease.+The+North+American+Crohn%27s+Study+Group+Investigators." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Methotrexate+for+the+treatment+of+Crohn%27s+disease.+The+North+American+Crohn%27s+Study+Group+Investigators.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000161-Bernstein1" id="pone.0000161-Bernstein1"></a>Bernstein CN, Artinian L, Anton PA, Shanahan F (1994) Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity. Dig Dis Sci  39: 1638â1641.  <ul class="find" data-citedArticleID="926426" data-doi="10.1007/bf02087769"><li><a href="http://dx.doi.org/10.1007/bf02087769" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Low-dose+6-mercaptopurine+in+inflammatory+bowel+disease+is+associated+with+minimal+hematologic+toxicity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Low-dose+6-mercaptopurine+in+inflammatory+bowel+disease+is+associated+with+minimal+hematologic+toxicity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000161-Coggin1" id="pone.0000161-Coggin1"></a>Coggin JH, Loosemore M, Martin WR (1966) Metabolism of 6-Mercaptopurine by Resistant <em>Escherichia coli</em> Cells. J Bacteriol  92: 446â454.  <ul class="find" data-citedArticleID="926434"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Metabolism+of+6-Mercaptopurine+by+Resistant+Escherichia+coli+Cells.&amp;auth=&amp;atitle=Metabolism+of+6-Mercaptopurine+by+Resistant+Escherichia+coli+Cells." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Metabolism+of+6-Mercaptopurine+by+Resistant+Escherichia+coli+Cells." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Metabolism+of+6-Mercaptopurine+by+Resistant+Escherichia+coli+Cells.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000161-Zimmerman1" id="pone.0000161-Zimmerman1"></a>Zimmerman EF, Magasanik B (1964) Utilization And Interconversion Of Purine Bases And Ribonucleosides By <em>Salmonella Typhimurium</em>. J Biol Chem  239: 293â300.  <ul class="find" data-citedArticleID="926470"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Utilization+And+Interconversion+Of+Purine+Bases+And+Ribonucleosides+By+Salmonella+Typhimurium.&amp;auth=&amp;atitle=Utilization+And+Interconversion+Of+Purine+Bases+And+Ribonucleosides+By+Salmonella+Typhimurium." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Utilization+And+Interconversion+Of+Purine+Bases+And+Ribonucleosides+By+Salmonella+Typhimurium." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Utilization+And+Interconversion+Of+Purine+Bases+And+Ribonucleosides+By+Salmonella+Typhimurium.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000161-1" id="pone.0000161-1"></a> (2006) Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) (2006)  Research Triangle Park, NC 27709: RTI International (<a href="http://www.taacf.org">http://www.taacf.org</a>).  <ul class="find" data-citedArticleID="926420"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Tuberculosis+Antimicrobial+Acquisition+and+Coordinating+Facility+%28TAACF%29+%282006%29&amp;auth=&amp;atitle=Tuberculosis+Antimicrobial+Acquisition+and+Coordinating+Facility+%28TAACF%29+%282006%29" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Tuberculosis+Antimicrobial+Acquisition+and+Coordinating+Facility+%28TAACF%29+%282006%29" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Tuberculosis+Antimicrobial+Acquisition+and+Coordinating+Facility+%28TAACF%29+%282006%29%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000161-Chiodini1" id="pone.0000161-Chiodini1"></a>Chiodini RJ, Van Kruiningin HJ, Thayer WJ Jr, Coutu J (1986) Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. JClinMicrobiol  24: 357â363.  <ul class="find" data-citedArticleID="926432"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Spheroplastic+phase+of+mycobacteria+isolated+from+patients+with+Crohn%27s+disease.&amp;auth=&amp;atitle=Spheroplastic+phase+of+mycobacteria+isolated+from+patients+with+Crohn%27s+disease." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Spheroplastic+phase+of+mycobacteria+isolated+from+patients+with+Crohn%27s+disease." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Spheroplastic+phase+of+mycobacteria+isolated+from+patients+with+Crohn%27s+disease.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0000161-Bertram1" id="pone.0000161-Bertram1"></a>Bertram MA, Inderlied CB, Yadegar S, Kolanoski P, Yamada JK, et al.  (1986) Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex. J Infect Dis  154: 194â195.  <ul class="find" data-citedArticleID="926428" data-doi="10.1093/infdis/154.1.194"><li><a href="http://dx.doi.org/10.1093/infdis/154.1.194" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Confirmation+of+the+beige+mouse+model+for+study+of+disseminated+infection+with+Mycobacterium+avium+complex." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Confirmation+of+the+beige+mouse+model+for+study+of+disseminated+infection+with+Mycobacterium+avium+complex.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0000161-Damato1" id="pone.0000161-Damato1"></a>Damato JJ, Collins MT (1990) Growth of Mycobacterium paratuberculosis in radiometric, Middlebrook and egg-based media. Vet Microbiol  22: 31â42.  <ul class="find" data-citedArticleID="926436" data-doi="10.1016/0378-1135(90)90122-c"><li><a href="http://dx.doi.org/10.1016/0378-1135(90)90122-c" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Growth+of+Mycobacterium+paratuberculosis+in+radiometric%2C+Middlebrook+and+egg-based+media." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Growth+of+Mycobacterium+paratuberculosis+in+radiometric%2C+Middlebrook+and+egg-based+media.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0000161-Rastogi1" id="pone.0000161-Rastogi1"></a>Rastogi N, Goh KS, Labrousse V (1992) Activity of clarithromycin compared with those of other drugs against <em>Mycobacterium paratuberculosis</em> and further enhancement of its extracellular and intracellular activities by ethambutol. AntimicrobAgents Chemother  36: 2843â2846.  <ul class="find" data-citedArticleID="926464" data-doi="10.1128/aac.36.12.2843"><li><a href="http://dx.doi.org/10.1128/aac.36.12.2843" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Activity+of+clarithromycin+compared+with+those+of+other+drugs+against+Mycobacterium+paratuberculosis+and+further+enhancement+of+its+extracellular+and+intracellular+activities+by+ethambutol." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Activity+of+clarithromycin+compared+with+those+of+other+drugs+against+Mycobacterium+paratuberculosis+and+further+enhancement+of+its+extracellular+and+intracellular+activities+by+ethambutol.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0000161-Kunze1" id="pone.0000161-Kunze1"></a>Kunze ZM, Wall S, Appelberg R, Silva MT, Portaels F, et al.  (1991) IS900, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in <em>Mycobacterium avium</em>. Molecular Microbiology  5: 2265â2272.  <ul class="find" data-citedArticleID="926454" data-doi="10.1111/j.1365-2958.1991.tb02157.x"><li><a href="http://dx.doi.org/10.1111/j.1365-2958.1991.tb02157.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=IS900%2C+a+new+member+of+a+widespread+class+of+atypical+insertion+sequences%2C+is+associated+with+pathogenicity+in+Mycobacterium+avium." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22IS900%2C+a+new+member+of+a+widespread+class+of+atypical+insertion+sequences%2C+is+associated+with+pathogenicity+in+Mycobacterium+avium.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0000161-Kunze2" id="pone.0000161-Kunze2"></a>Kunze ZM, Portaels F, McFadden JJ (1992) Biologically distinct subtypes of Mycobacterium avium differ in possession of insertion sequence IS901. J Clin Microbiol  30: 2366â2372.  <ul class="find" data-citedArticleID="926456"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Biologically+distinct+subtypes+of+Mycobacterium+avium+differ+in+possession+of+insertion+sequence+IS901.&amp;auth=&amp;atitle=Biologically+distinct+subtypes+of+Mycobacterium+avium+differ+in+possession+of+insertion+sequence+IS901." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Biologically+distinct+subtypes+of+Mycobacterium+avium+differ+in+possession+of+insertion+sequence+IS901." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Biologically+distinct+subtypes+of+Mycobacterium+avium+differ+in+possession+of+insertion+sequence+IS901.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0000161-Findley1" id="pone.0000161-Findley1"></a>Findley RS, Fortner CL (1996)  Methotrexate in Non Hodgkin's Lymphoma. In: Herfindal ET, Gourley DR, editors. Textbook of Therapeutics: Drugs and Disease Management. Sixth ed. Baltimore, MD: Williams &amp; Wilkins.. pp. 1509â1513.  <ul class="find-nolinks"></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.XML" value="68106"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.PDF" value="205815"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.t001.PNG_L" value="52630"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.t001.PNG_M" value="8320"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.t001.PNG_S" value="1514"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.t001.TIF" value="3316528"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.t001.PNG_I" value="3978"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g001.PNG_L" value="699909"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g001.PNG_M" value="38115"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g001.PNG_S" value="2446"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g001.TIF" value="1044060"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g001.PNG_I" value="14986"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g002.PNG_L" value="2174089"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g002.PNG_M" value="55761"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g002.PNG_S" value="2987"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g002.TIF" value="2752990"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000161.g002.PNG_I" value="20613"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000161&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000161" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000161&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000161&volume=&issue=&title=On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis&author_name=Robert%20J.%20Greenstein%2C%20Liya%20Su%2C%20Vahram%20Haroutunian%2C%20Azra%20Shahidi%2C%20Sheldon%20T.%20Brown&start_page=1&end_page=5" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000161" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000161" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000161" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000161&amp;t=On%20the%20Action%20of%20Methotrexate%20and%206-Mercaptopurine%20on%20M.%20avium%20Subspecies%20paratuberculosis" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000161&title=On%20the%20Action%20of%20Methotrexate%20and%206-Mercaptopurine%20on%20M.%20avium%20Subspecies%20paratuberculosis&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000161&amp;title=On%20the%20Action%20of%20Methotrexate%20and%206-Mercaptopurine%20on%20M.%20avium%20Subspecies%20paratuberculosis" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000161" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000161&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000161';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20On%20the%20Action%20of%20Methotrexate%20and%206-Mercaptopurine%20on%20M.%20avium%20Subspecies%20paratuberculosis http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000161" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000161" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">













          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Antibiotics%22" title="Search for articles in the subject area:'Antibiotics'"><div class="flagText">Antibiotics</div></a>
              <div data-categoryid="42767" data-articleid="23160"
                   data-categoryname="Antibiotics"
                   class="flagImage" title="Flag 'Antibiotics' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cancer+treatment%22" title="Search for articles in the subject area:'Cancer treatment'"><div class="flagText">Cancer treatment</div></a>
              <div data-categoryid="20025" data-articleid="23160"
                   data-categoryname="Cancer treatment"
                   class="flagImage" title="Flag 'Cancer treatment' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cytokines%22" title="Search for articles in the subject area:'Cytokines'"><div class="flagText">Cytokines</div></a>
              <div data-categoryid="47517" data-articleid="23160"
                   data-categoryname="Cytokines"
                   class="flagImage" title="Flag 'Cytokines' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Diluents%22" title="Search for articles in the subject area:'Diluents'"><div class="flagText">Diluents</div></a>
              <div data-categoryid="26441" data-articleid="23160"
                   data-categoryname="Diluents"
                   class="flagImage" title="Flag 'Diluents' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Inflammatory+bowel+disease%22" title="Search for articles in the subject area:'Inflammatory bowel disease'"><div class="flagText">Inflammatory bowel disease</div></a>
              <div data-categoryid="24885" data-articleid="23160"
                   data-categoryname="Inflammatory bowel disease"
                   class="flagImage" title="Flag 'Inflammatory bowel disease' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Methotrexate%22" title="Search for articles in the subject area:'Methotrexate'"><div class="flagText">Methotrexate</div></a>
              <div data-categoryid="24491" data-articleid="23160"
                   data-categoryname="Methotrexate"
                   class="flagImage" title="Flag 'Methotrexate' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Mycobacterium+avium+complex%22" title="Search for articles in the subject area:'Mycobacterium avium complex'"><div class="flagText">Mycobacterium avium complex</div></a>
              <div data-categoryid="44543" data-articleid="23160"
                   data-categoryname="Mycobacterium avium complex"
                   class="flagImage" title="Flag 'Mycobacterium avium complex' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Paratuberculosis%22" title="Search for articles in the subject area:'Paratuberculosis'"><div class="flagText">Paratuberculosis</div></a>
              <div data-categoryid="27327" data-articleid="23160"
                   data-categoryname="Paratuberculosis"
                   class="flagImage" title="Flag 'Paratuberculosis' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=6996'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=8865'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=9587&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
